pharma · Non-squamous Cell Non-Small Cell Lung Cancer
Henan Provincial People's
Henan Provincial People's Hospital
Henan Provincial People's is a pharma organization headquartered in CN. Primary therapeutic focus areas include Non-squamous Cell Non-Small Cell Lung Cancer. NovaPharmaNews links 1 clinical program(s), 0 drug profile(s),
CN HQ
NMPA registrant Type
Company details
- Status
- Public
- HQ
- CN
- Programs
- 1
- Drugs
- 2
- Patents
- 0
Anlotinib plus Pemetrexed
Phase 2 · small molecule · Non-squamous Cell Non-Small Cell Lung Cancer
Anlotinib plus Pemetrexed for Non-squamous Cell Non-Small Cell Lung Cancer is a Phase 2 program (small_molecule) at Henan Provincial People's Hospital with 1 ClinicalTrials.gov record(s).
Internal code ALTER-L025
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Henan Provincial People's Hospital
- Phase
- Phase 2
- Modality
- small_molecule
- Indication
- Non-squamous Cell Non-Small Cell Lung Cancer
- Status
- active
- Trials
- 1